Sabaa International Company for Pharmaceutical and Chemical Industry

CASE:SIPC Stock Report

Mkt Cap: ج.م269.3m

We’ve recently updated our valuation analysis.

Sabaa International Company for Pharmaceutical and Chemical Industry Valuation

Is SIPC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SIPC?

Other financial metrics that can be useful for relative valuation.

SIPC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue11.4x
Enterprise Value/EBITDA29.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does SIPC's PE Ratio compare to its peers?

The above table shows the PE ratio for SIPC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average3.3x
ADCI Arab Drug
3.7xn/aج.م345.4m
NIPH Nile for Pharmaceuticals and Chemical Industries
4.1xn/aج.م365.2m
CPCI Kahira Pharmaceuticals & Chemical Industries
4xn/aج.م666.2m
MPCI Memphis Pharmaceuticals & Chemical Industries
1.4xn/aج.م106.9m
SIPC Sabaa International Company for Pharmaceutical and Chemical Industry
55.6xn/aج.م269.3m

Price-To-Earnings vs Peers: SIPC is expensive based on its Price-To-Earnings Ratio (55.6x) compared to the peer average (3.3x).


Price to Earnings Ratio vs Industry

How does SIPC's PE Ratio compare vs other companies in the African Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a7.4%
n/an/an/a

Price-To-Earnings vs Industry: SIPC is expensive based on its Price-To-Earnings Ratio (55.6x) compared to the African Pharmaceuticals industry average (10x)


Price to Earnings Ratio vs Fair Ratio

What is SIPC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SIPC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio55.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SIPC's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SIPC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SIPC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SIPC's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies